SPC354
Selúmetíníb vetnissúlfat, þar með talið hver sem er af lausnarsamböndum eða vatnsfríum formum þar af
Status:
VeittApplication date:
29.10.2021Application published:
15.12.2021Grant published:
15.10.2023
Max expiry date:
11.12.2031Next due date:
31.12.2026Medicine name:
KoselugoMedicine for children:
No
Timeline
Today
29.10.2021Application
15.12.2021Publication
15.10.2023Registration
11.12.2031Expires
Marketing license
IS authorization number:
EU/1/21/1552/001Date:
20.7.2021
Foreign authorization number:
EU/1/21/1552Date:
17.6.2021
Owner
Name:
Array BioPharma Inc.Address:
3200 Walnut Street, Boulder, CO US
Name:
AstraZeneca ABAddress:
, Södertälje SE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP1968948
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 23.09.2023